Cited by 265Cervical Cancer and HPV ResearchWomen's cancer prevention and managementReproductive tract infections research

High‐risk HPV testing on self‐sampled versus clinician‐collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening

Snijders, Peter J.F., Verhoef, Viola M.J., Arbyn, Marc, Ogilvie, Gina, Minozzi, Silvia, Banzi, Rita, van Kemenade, Folkert J., Heideman, Daniëlle A.M. +1 more·2013·International Journal of Cancer

Abstract

This review elaborates on the accuracy and feasibility of human papillomavirus (HPV) self-sampling, i.e., offering self-sampling of (cervico-)vaginal cell material by women themselves in nonclinical settings for high-risk HPV (hrHPV) detection in the laboratory, for cervical screening. To that end a bibliographic database search (PubMed) was performed to identify studies (published between January 1992 and January 2012) that compared clinical accuracy of HPV testing on self-sampled material with that of cytology or HPV testing on clinician-taken samples, and studies comparing response to offering HPV self-sampling with a recall invitation. Overall, hrHPV testing on self-samples appeared to be at least as, if not more, sensitive for cervical intraepithelial neoplasia grade 2 or worse (CIN2+) as cytology on clinician-obtained cervical samples, though often less specific. In most studies, hrHPV testing on self- and clinician-sampled specimens is similarly accurate with respect to CIN2+ detection. Variations in clinical performance likely reflect the use of different combinations of collection devices and HPV tests. Because it is known that underscreened women are at increased risk of cervical cancer, targeting non-attendees of the screening program could improve the effectiveness of cervical screening. In developed countries offering self-sampling has shown to be superior to a recall invitation for cytology in re-attracting original non-attendees into the screening program. Addi…

Integrity signals

Registry

Crossref · 10.1002/ijc.27790

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Snijders, P. J. F., Verhoef, V. M. J., Arbyn, M., Ogilvie, G., Minozzi, S., Banzi, R., van Kemenade, F. J., Heideman, D. A. M., & Meijer, C. J. L. M.
Affiliations
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Institut Scientifique de Santé Publique (BE)
  • University of British Columbia (CA)
  • University of Turin (IT)
  • Mario Negri Institute for Pharmacological Research (IT)
Corresponding author
Snijders, Peter J.F.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2012-09-14
Volume
132
Issue
10
Pages
2223-2236
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W1988540981
Cited by
265
References
2
Citations by year
2026: 6 · 2025: 17 · 2024: 15 · 2023: 19 · 2022: 8 · 2021: 15 · 2020: 19 · 2019: 13 · 2018: 28 · 2017: 25 · 2016: 17 · 2015: 21 · 2014: 40 · 2013: 19 · 2012: 2
FWCI
3.26
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords
HPV self-sampling, high-risk HPV testing, cervical cancer screening, cervical intraepithelial neoplasia, cytology, screening accuracy, screening uptake, underscreened women, resource-limited settings, self-testing
MeSH terms
Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Feasibility Studies, Female, Humans, Therapeutic Irrigation, Mass Screening, Specimen Handling, Vaginal Smears, Papillomavirus Infections, Alphapapillomavirus, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review